Navigation Links
Breast Cancer Detection and Treatment Recovers Slowly from Big Losses During Recession

FARMINGTON, Conn., June 25, 2012 /PRNewswire-iReach/ -- Breast Cancer Diagnostic and Drug market are recovering after significant slowdown during the global recession. Having accurate market data and analysis will be essential to companies seeking to compete on the global stage as the market reemerges into success. With premium market research from the world's leading publishers, Global Information Inc. helps businesses stay on the cutting edge with the best forecasts, research, and analyses.


Breast Cancer Diagnostic and Drug Technologies: Global Markets

The global market for breast cancer diagnostics and drug technologies shrank significantly in 2011. The predictive breast cancer diagnostic and drug technology market was valued at $23.4 billion in 2010 and came down to $21.2 billion in 2011, while the Breast cancer drug market size reached $12.7 billion in 2010 and came down to $10.2 billion in 2011. The only market to show modest growth was the quantitative immunofluorescence market, which reached $5.7 billion in 2010 and $5.9 billion in 2011 respectively. This market also shows the biggest growth potential, with forecast CAGR of 3.1% by 2016, while breast cancer drugs will reach $11.2 billion by 2016 at a CAGR of 1.9%.

In their new report "Breast Cancer Diagnostic and Drug Technologies: Global Markets", BCC offers a comprehensive review of emerging breast cancer personalized and predictive diagnostic tests, particularly with regard to companion tests, tumor markers and gene profiling assays relevant for breast cancer prognosis and diagnosis; including SWOT analysis and market review. The report also reviews the current state of the companion diagnostics industry and the new technologies in assay development, and describes an overview of major biotechnology and pharmaceutical companies involved in developing innovative, targeted breast cancer treatments. In addition, the report also provides information regarding the less-developed sectors of this market and presents a list of current companies that have new predictive testing products and drugs in development for breast cancer.

An Executive Summary of this analysis and a free sample of the full report are available at

Breast Cancer Partnering 2007-2012

"Breast Cancer Partnering 2007-2012" provides access to the breast cancer partnering deals and agreements entered into by the world's leading healthcare companies, including analysis by industry sector, stage of development, and technology type. The report contains over 250 links to online copies of actual breast cancer deals and contract documents, offering details insight press releases do not disclose.

The report includes a comprehensive directory of breast cancer partnering deals signed and announced since 2007. Leading breast cancer deals are listed by value, industry sector, Stage of development at signing, Deal component and technology type.

An Executive Summary of this analysis and a free sample of the full report are available at

About Global Information Inc. Global Information (GII) ( is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796,

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
2. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
3. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
4. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
6. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
8. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
9. Generex Announces Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
10. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
11. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  QT Vascular Ltd., ... and together with its subsidiaries, TriReme Medical LLC and ... company engaged in the design, assembly and distribution of ... vascular disease, is pleased to announce that a three-judge ... Court of Appeals for the Federal Circuit ("Federal Circuit") ...
(Date:11/30/2015)... Nov. 30, 2015  DURECT Corporation (Nasdaq: ... Matt Hogan , Chief Financial Officer, will ... on Tuesday, December 8 at 2:45 pm ... at the Westin Grand Central Hotel in ... for one-on-one meetings at this conference; interested ...
(Date:11/30/2015)... DUBLIN , Nov. 30, 2015 ... addition of the "Orphan Drugs Market 2015-2019" ... ) has announced the addition of the ... their offering. --> Research and Markets ... the "Orphan Drugs Market 2015-2019" report ...
Breaking Medicine Technology:
(Date:11/30/2015)... VA (PRWEB) , ... November 30, 2015 , ... ... Research Foundation (Meso Foundation) released information for caregivers and held two webinars on ... are available on demand free of charge at . , With ...
(Date:11/30/2015)... Irving, TX (PRWEB) , ... November 30, 2015 ... ... for plastic surgery and dermatology, is proud to announce that its ThermiRFR temperature ... Europe. , ThermiRF is an innovative multi-application radiofrequency platform which uses temperature as ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum of ... ushering in a new era of publicly accessible automated technology. Now, by popular ... to offer guests an up-close look at the shuttle at MOSI’s main entrance. ...
(Date:11/30/2015)... ... November 30, 2015 , ... On Saturday, October 24th, 2015, at ... an annual fundraising event, a 5K walk known as “Making Strides Against Breast Cancer”. ... abuse which is also located in Battle Creek, joined in for this campaign that ...
(Date:11/30/2015)... ... 2015 , ... During the week of Thanksgiving, the Mesothelioma ... its research, education, support, and advocacy efforts. The campaign is held every year-end ... Applied Research Foundation, which also goes by Meso Foundation, holds the highest ...
Breaking Medicine News(10 mins):